edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Lavie Bio aims to improve food quality, sustainability and agricultural productivity through the introduction of microbiome-based ag-biological products. Using proprietary computational predictive technologies, Lavie Bio is implementing a ‘biology-driven design’ approach to introduce ‘next-generation’ bio-stimulants and bio-pesticides.
The interview features CEO Ido Dor and board member Kristian Bjørneboe.
Lavie Bio is a private subsidiary of Edison client Evogene (TASE: EVGN, NASDAQ: EVGN), a leading company in leveraging computational biology to design novel products for life science-based industries including human health, agriculture and industrial applications. To achieve its mission, Evogene established a unique Computational Predictive Biology (CPB) platform, leveraging the revolutions in big data and artificial intelligence, and incorporating a deep understanding of biology.
Get access to the very latest content matched to your personal investment style.